Global Footprint CONMED operates across the United States and more than 20 international locations, serving multiple specialties including Orthopedic, Laparoscopic, Robotic & Open Surgery, Gastroenterology & Pulmonology, and Cardiology & Critical Care. This expansive footprint enables the sales team to target large hospital networks with integrated surgical and monitoring solutions and to pursue cross-selling opportunities across regions and disciplines.

Value Proposition ROI The company's mission centers on delivering exceptional patient outcomes through accessible solutions, providing a strong basis for value-based selling to hospital administrators and procurement teams. Position CONMED's products as offering improved clinical outcomes, operational efficiency, and potential cost reductions per case, supported by outcome data and service capabilities.

Financial Leadership CFO appointment anticipated for July 15, 2026 signals a focus on financial discipline, growth financing options, and potential strategic investments or M&A activity. This opens doors for sales propositions around flexible financing, leasing, service contracts, and bundled equipment-and-services deals that align with hospital budgeting cycles.

Technology Led Growth CONMED's tech stack includes cloud platforms, developer tools, and automation, indicating a favorable environment for software-enabled services, remote monitoring, and data analytics integrations. Opportunities exist to offer digital workflow optimization, training platforms, and analytics services to hospital sites and distributors, enhancing adoption and stickiness.

Product Mix Resilience First quarter 2026 net sales declined modestly due to the exit of certain GI products, highlighting exposure to product-line volatility. This creates sales opportunities to propose replacement GI solutions or cross-sell into Orthopedic, Robotic, or Cardiology portfolios, as well as to introduce broader product bundles that mitigate revenue risk.